Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational Research

Small cell lung cancer (SCLC) is an aggressive, complex disease with a distinct biology that contributes to its poor prognosis. Management of SCLC is still widely limited to chemotherapy and radiation therapy, and research recruitment still poses a considerable challenge. Here, we review the current...

Descripción completa

Detalles Bibliográficos
Autores principales: Subbiah, Shanmuga, Nam, Arin, Garg, Natasha, Behal, Amita, Kulkarni, Prakash, Salgia, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464169/
https://www.ncbi.nlm.nih.gov/pubmed/32751469
http://dx.doi.org/10.3390/jcm9082433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464169/
https://www.ncbi.nlm.nih.gov/pubmed/32751469
http://dx.doi.org/10.3390/jcm9082433

Ejemplares similares